CSCS WILFRED BIGELOW LECTURE

Saturday, October 28, 2023

14:00 – 15:00 EST

Location: Palais, 518ABC

Target Audience: Cardiac surgeons, Clinical cardiologists, General: All cardiovascular (clinical and research) health professionals

Co-Chair(s)

Subodh Verma, MD, PhD (he/him/his)

Cardiac Surgeon
CSCS
University of Toronto
Ansar Hassan, MD PhD (he/him/his)

Cardiac Surgeon
Maine Medical Center
Maine Medical Center

Disclosure(s):

Subodh Verma, MD, PhD: Amarin: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Amgen: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); AstraZeneca: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Bayer: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Boehringer-Ingelheim: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Canadian Medical and Surgical Knowledge Translation Research Group: Speaker/Honoraria (Ongoing); Eli Lilly: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); HLS Therapeutics: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Janssen: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Novartis: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Novo Nordisk: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Pfizer: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); PhaseBio: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated, February 17, 2023), Speaker/Honoraria (Terminated, February 17, 2023); S&L Solutions: Speaker/Honoraria (Ongoing); Sanofi: Speaker/Honoraria (Ongoing)

Learning Objectives / Objectifs d'apprentissage:

At the end of this session participants will be able to / Au terme de cette conférence, vous serez:

Interpret clinical trial data on treatment options for patients with heart valve disease;
review cause, nature and progression of heart valve disease; and
recognize surgical and non-surgical management techniques for individuals with heart valve disease.

Session Description: This is the flagship session held every year at CSCS. The objective is to bring together world renowned speakers who span cardiac surgery and other surgical disciplines. This year we are privileged to have Dr. Duke Cameron who will speak on: "Heart Valve Disease: At the intersection of sceince, surgery and collaboration".

Presentations:

14:00 – 14:45 EST

HEART VALVE DISEASE: AT THE INTERSECTION OF SCEINCE, SURGERY AND COLLABORATION
Presenter: Duke E. Cameron (he/him/his) – Johns Hopkins Medical Institutions
14:45 – 14:50 EST

PAUL CARTIER AWARD
Presenter: Joel Bierer, MD – Dalhousie University